I obtained my PhD in Microbiology and Immunology at the University of Ottawa prior to beginning my postdoctoral training at the University of British Columbia, where I transitioned into translational cancer research. My current research focuses on uncovering transcriptional networks and downstream target proteins that drive esophageal cancer progression. I aim to identify novel, targetable vulnerabilities that could inform the development of more effective precision oncology therapeutics. My work bridges fundamental discovery with translational applications, advancing precision oncology therapeutic development through academic-industry collaboration.